Archives

by in
Entry Author Date Location
Infinity Pharmaceuticals Gets Back Full Rights to Cancer Drugs From AstraZeneca 12/11/08 Boston
Resolvyx Closes in on Clinical Trials, Radius Health Reels in $15M, Luke Zeros in on Public Biotechs’ Bottom Line, & More Boston-Area Life Sciences News 11/26/08 Boston
Biotech Survival Index: Boston Life Sciences Companies Brace for Long, Hard Winter 11/25/08 Boston
SunEthanol Picks Up $25M, New Name; Infinity Pharma Pairs with Purdue Pharma; In-Q-Tel Taps Two Local Firms, & More Boston-Area Deals News 11/24/08 Boston
Vertex, Ariad, and Infinity Reach Clinical Milestones; FDA Grants Dying Cancer Patient Access to Tysabri; Genzyme Exec Takes Pervasive Helm; & More Boston-Area Life Sciences News 10/22/08 Boston
Infinity Starts Trial of Hedgehog Pathway Blocker 10/16/08 Boston
Vertex Cystic Fibrosis Program on the Rise, Biogen and Partner Fall on Tysabri News, Alnylam Stakes RNAa IP Claim, & More Life Sciences News 08/06/08 Boston
Infinity Pharmaceuticals Starts First Clinical Trial of Oral Hsp-90 Blocker 07/30/08 Boston
Infinity Adds Two New Members To Board of Directors 07/22/08 Boston
MIT and Startup Sue Affymetrix, Enlight Garners Big Pharma Backers, Genocea Targets Cheaper Vaccines, & More Life Sciences News 07/16/08 Boston
Infinity Pharmaceuticals Pulls Plug on Treatment for Prostate Cancer 07/14/08 Boston
Xconomy Forum, December 5: The Future of Innovation in New England 11/08/07 Boston
Page 3 of 3 « previous page